Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net (loss)	$ (708,055)	$ (1,206,905)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Depreciation		759
Common stock issued for services rendered	299,333	796,797
Accounts payable and accrued expenses	33,571	11,652
Due from related party	(21,970)	(73,048)
Net cash (used in) operating activities:	(397,121)	(470,745)
Cash flows from investing activities
Patent cost	(7,000)
Net cash (used in) investing activities:	(7,000)
Cash flows from financing activities
Proceeds from issuance of common stock	250,000	150,000
Proceeds from exercise of options	7,500	58,000
Proceeds from exercise of warrants		118,446
Repayment of officer loan payable		(2,400)
Net cash provided by financing activities	257,500	324,046
Net increase/(decrease) in cash	(146,622)	(146,699)
Cash beginning of period	152,526	400,848
Cash end of period	5,905	254,149
Common stock issued for accounts payable		72,375
Deferred revenue		276,950
Prepayments of expenses through issuance of common stock		66,300
Interest
Income taxes